MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies ...

SAN FRANCISCO--(BUSINESS WIRE)--MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that ...

Traditionally, imaging workflows required significant manual interaction and time investment from the user. The addition of automation has decreased user time commitment and increased data output.

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

SAN JOSE — A biotech firm with a global reach has bought a big North San Jose tech building in a deal that shows at least some office buildings can capture higher values even in the face of ...

Slingshot Biosciences, the pioneer of synthetic cell mimic technology for flow cytometry controls, today announced the appointment of Jim ...

Did our AI summary help? Miltenyi Biotec, the German cell and gene therapy (CGT) specialist that quietly powers much of the world’s CAR‑T manufacturing ecosystem, is preparing a major push into ...

(RTTNews) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the Court's ...

In this webinar, Evelien Van Hamme and Elina Kuznecova will discuss core facility perspectives and their experiences with the MACSima spatial proteomics platform at the Flemish Institute for ...

For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to ...